Confluent, Inc.(CFLT)Earnings, Financials & Key RatiosConfluent, Inc. (CFLT) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2025Q4
while the company has achieved a positive 13.2% free cash flow margin, the high valuation at a 60.63 forward P/E and persistent dilution from $101.6 million in quarterly stock-based compensation warrant a cautious approach.
Confluent, Inc. (CFLT) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Confluent, Inc. (CFLT) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 11, 2026 | $0.12vs $0.10+21.0% | $315Mvs $308M+2.2% |
| Q4 2025 | Oct 27, 2025 | $0.13vs $0.10+30.0% | $299Mvs $308M-3.1% |
| Q3 2025 | Jul 30, 2025 | $0.09vs $0.08+12.5% | $282Mvs $293M-3.6% |
| Q2 2025 | Apr 30, 2025 | $0.08vs $0.07+14.3% | $271Mvs $264M+2.5% |
Recent stock market news and headlines for Confluent, Inc. (CFLT)
LOUISVILLE, Ky. -- June 16, 2026, June 16, 2026 (GLOBE NEWSWIRE) -- Chronic pain is shaping how millions of Americans live, move, sleep, work, and recover. New findings from Confluent Health suggest the healthcare system may still be falling short in addressing it.
Key metrics vs top competitors for Confluent, Inc. (CFLT)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $30.99 | $10.65B | -36.03 | 21.08% | -25.31% | -27.72% | — | |
| $15.93 | $1.56B | -132.75 | 23.25% | 0.33% | 0.27% | — | |
| $256.81 | $91.41B | 856.03 | 27.68% | 3.69% | 3.78% | — | |
| $45.11 | $13.15B | 83.54 | 18.82% | 8.06% | 6% | — | |
| $59.46 | $6.15B | 17.34 | 17.26% | 21.14% | 37.43% | — | |
| $32.59 | $5.5B | -93.11 | 25.81% | -2.49% | -2.54% | — |
Confluent, Inc. (CFLT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Confluent, Inc. (CFLT) SEC filings — annual & quarterly reports (10-K, 10-Q)
Mar 17, 2026·SEC
Feb 25, 2026·SEC
Feb 12, 2026·SEC
Get notified when CFLT posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Confluent, Inc. (CFLT) stock FAQ — growth, dividends, profitability & financials explained
Confluent, Inc. (CFLT) reported $1.17B in revenue for fiscal year 2025. This represents a 679% increase from $149.8M in 2019.
Confluent, Inc. (CFLT) grew revenue by 21.1% over the past year. This is strong growth.
Confluent, Inc. (CFLT) reported a net loss of $295.3M for fiscal year 2025.
Confluent, Inc. (CFLT) has a return on equity (ROE) of -27.7%. Negative ROE indicates the company is unprofitable.
Confluent, Inc. (CFLT) generated $50.5M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
